Berlex Mirena Patients Will Receive Replacement Reminders After Five Years
This article was originally published in The Gray Sheet
Executive SummaryBerlex is developing a patient reminder program for women implanted with the Mirena levonorgestrel-releasing intrauterine device. FDA approved the product Dec. 6 for the prevention of pregnancy for up to five years.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.